Beta Bionics (Nasdaq:BBNX) announced today that it went public after pricing a significantly upsized initial public offering ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).

The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline ...

Insulet’s Omnipod 5 with the Dexcom G6 CGM. [Image from Insulet] Insulet (Nasdaq:PODD) announced today that it launched the Omnipod 5 system in five more European countries. The company now offers the ...

The Isaac blood glucose alert device. [Image courtesy of PreEvnt] PreEvnt recently announced plans to introduce Isaac, its non-invasive alert device for monitoring blood glucose levels. Isaac, which ...

Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support. The solution combines connected care, remote patient monitoring and digital ...

Analysts called a recent stock sell-off at Embecta (Nasdaq:EMBC) “unwarranted” and believe the company is moving in the right direction despite recent challenges. BTIG’s Marie Thibault, Sam Eiber and ...